Biomarkers & Precision Medicine US 2025

Tempus is advancing precision medicine through the practical application of artificial intelligence in healthcare. We are pleased to attend the Biomarkers & Precision Medicine US 2025 and present how Tempus can help you accelerate biomarker discovery by leveraging our end-to-end spatial services and licensable multimodal data library.

Schedule a meeting with us

Speaking Session

Speaking Session

Time
2:05pm PT

Date
Tuesday, October 28

Location
Conference Room 4

Speakers
Shing Shing Ho, Associate Director, Machine Learning (Tempus)
Arjun Ishwar, Solutions Director, Omics (Tempus)

Uncovering spatial biomarkers that differentiate responders in NSCLC and CRC with Integrated Visium HD Data: A case study with AstraZeneca

Learn about Tempus’ protocol for generating high-quality spatial transcriptomic data from a real-world clinical next-generation sequencing pipeline and our Visium HD service capabilities.

Explore how we pair spatial data with our licensable real-world data cohorts and associate spatial features with biomarkers from bulk DNA, RNA, and H&E, such as our Immune Profile Score.

Review a case study with AstraZeneca that demonstrates how spatial features can identify slow progressors to immunotherapies beyond traditional biomarkers.

Add to calendar

Schedule a meeting with us

We'll be in touch shortly.